In Hyun Park

Summary

Affiliation: Centre of Integrative Psychiatry (ZIP
Country: Germany

Publications

  1. ncbi Disease-specific induced pluripotent stem cells
    In Hyun Park
    Department of Medicine, Division of Pediatric Hematology Oncology, Children s Hospital Boston, and Dana Farber Cancer Institute, Boston, MA 02115, USA
    Cell 134:877-86. 2008
  2. ncbi Regulatory networks define phenotypic classes of human stem cell lines
    Franz Josef Muller
    Center for Regenerative Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA
    Nature 455:401-5. 2008
  3. ncbi A bioinformatic assay for pluripotency in human cells
    Franz Josef Muller
    Zentrum für Integrative Psychiatrie, Kiel, Germany
    Nat Methods 8:315-7. 2011
  4. ncbi Mammalian target of rapamycin (mTOR) signaling is required for a late-stage fusion process during skeletal myotube maturation
    In-Hyun Park
    Department of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
    J Biol Chem 280:32009-17. 2005
  5. ncbi Reprogramming of human somatic cells to pluripotency with defined factors
    In Hyun Park
    Division of Pediatric Hematology Oncology, Children s Hospital Boston and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Nature 451:141-6. 2008
  6. ncbi Debugging cellular reprogramming
    In-Hyun Park
    Nat Cell Biol 9:871-3. 2007
  7. ncbi Generation of human-induced pluripotent stem cells
    In Hyun Park
    Division of Pediatric Hematology Oncology, Children s Hospital Boston, 300 Longwood Avenue, Boston, Massachusetts 02115, USA
    Nat Protoc 3:1180-6. 2008

Collaborators

Detail Information

Publications7

  1. ncbi Disease-specific induced pluripotent stem cells
    In Hyun Park
    Department of Medicine, Division of Pediatric Hematology Oncology, Children s Hospital Boston, and Dana Farber Cancer Institute, Boston, MA 02115, USA
    Cell 134:877-86. 2008
    ..Such disease-specific stem cells offer an unprecedented opportunity to recapitulate both normal and pathologic human tissue formation in vitro, thereby enabling disease investigation and drug development...
  2. ncbi Regulatory networks define phenotypic classes of human stem cell lines
    Franz Josef Muller
    Center for Regenerative Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA
    Nature 455:401-5. 2008
    ..Our results offer a new strategy for classifying stem cells and support the idea that pluripotency and self-renewal are under tight control by specific molecular networks...
  3. ncbi A bioinformatic assay for pluripotency in human cells
    Franz Josef Muller
    Zentrum für Integrative Psychiatrie, Kiel, Germany
    Nat Methods 8:315-7. 2011
    ..Here we report PluriTest, a robust open-access bioinformatic assay of pluripotency in human cells based on their gene expression profiles...
  4. ncbi Mammalian target of rapamycin (mTOR) signaling is required for a late-stage fusion process during skeletal myotube maturation
    In-Hyun Park
    Department of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
    J Biol Chem 280:32009-17. 2005
    ....
  5. ncbi Reprogramming of human somatic cells to pluripotency with defined factors
    In Hyun Park
    Division of Pediatric Hematology Oncology, Children s Hospital Boston and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Nature 451:141-6. 2008
    ..These data demonstrate that defined factors can reprogramme human cells to pluripotency, and establish a method whereby patient-specific cells might be established in culture...
  6. ncbi Debugging cellular reprogramming
    In-Hyun Park
    Nat Cell Biol 9:871-3. 2007
  7. ncbi Generation of human-induced pluripotent stem cells
    In Hyun Park
    Division of Pediatric Hematology Oncology, Children s Hospital Boston, 300 Longwood Avenue, Boston, Massachusetts 02115, USA
    Nat Protoc 3:1180-6. 2008
    ..Overall, it takes 2 months to complete reprogramming human primary fibroblasts starting from biopsy...